Ovarian Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are female and under 40 years old
- You are unable or unwilling to use egg or embryo freezing alone as a way to preserve your fertility
- You are scheduled to have surgery, chemotherapy, medication, or radiation to treat or prevent a medical condition or cancer that carries a risk of permanently stopping your ovaries from working
- Or, you have a medical condition or cancer that requires the removal of all or part of one or both ovaries
- Or, you have been newly diagnosed or have a returning illness — and if your condition has returned, you have not yet had any treatment that is likely to permanently stop your ovaries from working
- You have two ovaries, if the reason for joining is to have one ovary removed purely for fertility preservation purposes
Who may not be able to join:
- You have a psychological or psychiatric condition, or another condition, that prevents you from being able to give fully informed consent to participate
- You have an existing medical condition that would significantly raise your risk of complications from anesthesia or surgery
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kyle Orwig, PhD, University of Pittsburgh/ University of Pittsburgh Medical Center
Phone: 4126417475
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Develop techniques for long-term preservation of female ovarian function through cryopreservation (freezing) of ovarian tissue and/or cells prior to therapies that are likely to cause infertility (e.g., chemotherapy, radiation).; Maintain cryopreserved ovarian tissue and/or cells for participating patients as a resource for future elective procedures to attempt fertility restoration.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.